Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Association of thyroid function and thyroid hormone sensitivity with all-cause and cardiovascular mortality in euthyroid patients with MASLD

Xinghua Zhang
1
,
Xiaoling Xing
1
,
Sheng Mao
1
,
Min Qi
1
,
Yanrui Xin
1
,
Xinyu Ma
1
,
Rui Huang
2

  1. The Fifth People’s Hospital of Datong, China
  2. People’s Hospital of Xin jiang Uygur Autonomous Region, China
Clin Exp HEPATOL 2025; 11, 4
DOI: https://doi.org/10.5114/ceh.2025.155479
Online publish date: 2025/10/27
Article file
- Association.pdf  [0.60 MB]
Get citation
 
PlumX metrics:
 
1. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022; 7: 851-861.
2. Wong VW, Ekstedt M, Wong GL, Hagström H. Changing epidemiology, global trends and implications for outcomes of
3. NAFLD. J Hepatol 2023; 79: 842-852.
4. Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 2013; 48: 434-441.
5. Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 2017; 377: 2063-2072.
6. Huang DQ, Singal AG, Kono Y, et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab 2022; 34: 969-977.e962.
7. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020; 73: 202-209.
8. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 2024; 81: 492-542.
9. Xu C, Xu L, Yu C, et al. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxf) 2011; 75: 240-246.
10. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006; 26: 856-863.
11. Wang B, Wang B, Yang Y, et al. Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients. BMC Endocr Disord 2021; 21: 27.
12. Ritter MJ, Amano I, Hollenberg AN. Thyroid hormone signaling and the liver. Hepatology 2020; 72: 742-752.
13. Piantanida E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest 2020; 43: 885-899.
14. Manka P, Coombes JD, Boosman R, et al. Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Lett 2018; 419: 175-186.
15. Kizivat T, Maric I, Mudri D, et al. Hypothyroidism and nonalcoholic fatty liver disease: Pathophysiological associations and therapeutic implications. J Clin Transl Hepatol 2020; 8: 347-353.
16. Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol 2018; 14: 259-269.
17. Pagadala MR, Zein CO, Dasarathy S, et al. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig Dis Sci 2012; 57: 528-534.
18. Borges-Canha M, Neves JS, Mendonça F, et al. Thyroid function and the risk of non-alcoholic fatty liver disease in morbid obesity. Front Endocrinol (Lausanne) 2020; 11: 572128.
19. Jaruvongvanich V, Sanguankeo A, Upala S. Nonalcoholic fatty liver disease is not associated with thyroid hormone levels and hypothyroidism: A systematic review and meta-analysis. Eur Thyroid J 2017; 6: 208-215.
20. Gu Y, Wu X, Zhang Q, et al. High-normal thyroid function predicts incident nonalcoholic fatty liver disease among middle-aged and older euthyroid subjects. J Gerontol A Biol Sci Med Sci 2022; 77: 197-203.
21. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 5483-5488.
22. Asvold BO, Bjøro T, Platou C, Vatten LJ. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway. Clin Endocrinol (Oxf) 2012; 77: 911-917.
23. Zhang Y, Chang Y, Ryu S, et al. Thyroid hormones and mortality risk in euthyroid individuals: the Kangbuk Samsung health study. J Clin Endocrinol Metab 2014; 99: 2467-2476.
24. van der Spek AH, Fliers E, Boelen A. The classic pathways of thyroid hormone metabolism. Mol Cell Endocrinol 2017; 458: 29-38.
25. Mehran L, Delbari N, Amouzegar A, et al. Reduced sensitivity to thyroid hormone is associated with diabetes and hypertension. J Clin Endocrinol Metab 2022; 107: 167-176.
26. Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care 2019; 42: 303-310.
27. Wan H, Yu G, Xu S, et al. Central sensitivity to free triiodothyronine with MAFLD and its progression to liver fibrosis in euthyroid adults. J Clin Endocrinol Metab 2023; 108: e687-e697.
28. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
29. Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol (Oxf) 2009; 71: 529-534.
30. Pohlenz J, Weiss RE, Macchia PE, et al. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab 1999; 84: 3919-3928.
31. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
32. Takamura N, Hayashida N, Maeda T. Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism. JAMA 2010; 304: 2481-2482; author reply 2482.
33. Tran TV, Kitahara CM, Leenhardt L, et al. The effect of thyroid dysfunction on breast cancer risk: an updated meta-analysis. Endocr Relat Cancer 2023; 30: e220155.
34. Bano A, Chaker L, Mattace-Raso FUS, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: The Rotterdam Study. Circ Res 2017; 121: 1392-1400.
35. Cappola AR, Arnold AM, Wulczyn K, et al. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metab 2015; 100: 1088-1096.
36. Waring AC, Arnold AM, Newman AB, et al. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 2012; 97: 3944-3950.
37. Pearce SH, Razvi S, Yadegarfar ME, et al. Serum thyroid function, mortality and disability in advanced old age: The Newcastle 85+ Study. J Clin Endocrinol Metab 2016; 101: 4385-4394.
38. Ceresini G, Marina M, Lauretani F, et al. Relationship between circulating thyroid-stimulating hormone, free thyroxine, and free triiodothyronine concentrations and 9-year mortality in euthyroid elderly adults. J Am Geriatr Soc 2016; 64: 553-560.
39. Yu G, Liu S, Song C, et al. Association of sensitivity to thyroid hormones with all-cause mortality in euthyroid US adults: A nationwide cohort study. Eur Thyroid J 2024; 13: e230130.
40. Mavromati M, Jornayvaz FR. Hypothyroidism-associated dyslipidemia: potential molecular mechanisms leading to NAFLD. Int J Mol Sci 2021; 22: 12797.
41. Ferrandino G, Kaspari RR, Spadaro O, et al. Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms. Proc Natl Acad Sci U S A 2017; 114: E9172-e9180.
42. Kim D, Vazquez-Montesino LM, Escober JA, et al. Low thyroid function in nonalcoholic fatty liver disease is an independent predictor of all-cause and cardiovascular mortality. Am J Gastroenterol 2020; 115: 1496-1504.
43. Sun Y, Teng D, Zhao L, et al. Impaired sensitivity to thyroid hormones is associated with hyperuricemia, obesity, and cardiovascular disease risk in subjects with subclinical hypothyroidism. Thyroid 2022; 32: 376-384.
44. Alonso SP, Valdés S, Maldonado-Araque C, et al. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study. Eur J Endocrinol 2021; 186: 95-103.
45. Bilgin H, Pirgon Ö. Thyroid function in obese children with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2014; 6: 152-157.
46. Zhu P, Lao G, Chen C, et al. TSH levels within the normal range and risk of cardiovascular and all-cause mortality among individuals with diabetes. Cardiovasc Diabetol 2022; 21: 254.
47. Inoue K, Tsujimoto T, Saito J, Sugiyama T. Association between serum thyrotropin levels and mortality among euthyroid adults in the United States. Thyroid 2016; 26: 1457-1465.
48. Qin Z, Muhanhali D, Ling Y. Impaired thyroid hormone sensitivity increases risk of cardiovascular events in patients undergoing coronary angiography. J Clin Endocrinol Metab 2024; 109: 1550-1564.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.